Inventor
FANSLOW WILLIAM C
US22 patents
⚠️ This page may combine multiple inventors who share the name “FANSLOW WILLIAM C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNEX CORP
19 patentsUS6087329AJul 11, 2000
CD40 ligand polypeptide
IMMUNEX CORP122 citations99
US6264951B1Jul 24, 2001
Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L
IMMUNEX CORP86 citations97
US5962406AOct 5, 1999
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
IMMUNEX CORP96 citations97
US5869286AFeb 9, 1999
Receptor that binds IL-17
IMMUNEX CORP81 citations97
US6680057B1Jan 20, 2004
Methods of treating autoimmune disease by administering interleukin-17 receptor
IMMUNEX CORP43 citations96
US6410711B1Jun 25, 2002
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP64 citations96
US6197525B1Mar 6, 2001
Assay kits for detection and methods of inhibiting IL-17 binding
IMMUNEX CORP46 citations96
US6191104B1Feb 20, 2001
Methods of treating graft rejection with the IL-17 receptor
IMMUNEX CORP41 citations96
US6100235AAug 8, 2000
Methods of treating immune and inflammatory response with IL-17 receptors
IMMUNEX CORP48 citations96
US6096305AAug 1, 2000
Receptor that binds IL-17
IMMUNEX CORP46 citations96
US6072037AJun 6, 2000
Antibodies to the IL-17 receptor
IMMUNEX CORP60 citations96
US6072033AJun 6, 2000
Receptor that binds IL-17
IMMUNEX CORP63 citations96
US5981724ANov 9, 1999
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP65 citations96
US5961974AOct 5, 1999
Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same
IMMUNEX CORP78 citations96
US6290972B1Sep 18, 2001
Method of augmenting a vaccine response by administering CD40 ligand
IMMUNEX CORP26 citations92
US7432237B2Oct 7, 2008
Methods of treating asthma by administering interleukin-17 receptor
IMMUNEX CORP9 citations84
US7273843B2Sep 25, 2007
Methods of treating allergy by administering interleukin-17 receptor
IMMUNEX CORP7 citations74
US7309489B1Dec 18, 2007
Mouse CD40 ligand-specific antibodies and hybridomas
IMMUNEX CORP1 citations63
US5223605AJun 29, 1993
Interleukin-4 binding protein-γ
IMMUNEX CORP2 citations63